Clinical Trials Browser

INDUSTRY × alovudine × CNS × Clear all

NCT01480583 2016-07-13

GRABM-B

Phase 2 Completed

Brain Neoplasms, Breast Neoplasms

NCT00553748 2008-07-03

Phase I, Open Label, Single Center Safety Study of [F-18]FLT

Phase 1 Completed

Brain Neoplasms